Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The mutation on EBP can cause Conradi-Hunermann syndrome, an inborn error.
|
31165728 |
2019 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
Biomarker
|
disease |
BEFREE |
X-linked dominant chondrodysplasia punctata type 2 (CDPX2) is a condition involving facial, skin, and skeletal dysplasia as a result of a mutation in emopamil binding protein (EBP).
|
30608402 |
2019 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
New splicing pathogenic variant in EBP causing extreme familial variability of Conradi-Hünermann-Happle Syndrome.
|
30135486 |
2018 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
The aim of our study is to identify EBP mutation in a unique case of Conradi-Hünermann-Happle syndrome with rare psoriasiform lesions.
|
25814754 |
2015 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Conradi-Hünermann-Happle syndrome (CDPX2, OMIM 302960) is an inherited X-linked dominant variant of chondrodysplasia punctata (CP) caused by mutations in one gene of the distal pathway of cholesterol biosynthesis.
|
24036494 |
2014 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
These males exhibit a phenotype similar to CDPX2 due to either somatic mosaicism or a 47, XXY karyotype in association with a null EBP allele.
|
24700572 |
2014 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations in EBP have previously been associated with Conradi-Hunermann-Happle syndrome (CHH), an X-linked dominant disorder characterized by skeletal dysplasia, skin, and ocular abnormalities, which is usually lethal in males.
|
24459067 |
2014 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Conradi-Hünermann-Happle syndrome (CDPX2, OMIM 302960) is an inherited X-linked dominant variant of chondrodysplasia punctata which primarily affects the skin, bones and eyes.
|
22121851 |
2012 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Conradi-Hünermann-Happle syndrome is caused by mutations in the gene EBP encoding Δ(8)-Δ(7) sterol isomerase emopamil-binding protein.
|
21931045 |
2011 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the EBP gene cause X-linked dominant chondrodysplasia punctata (CDPX2) which can be considered as a phenocopy of warfarin embryopathy.
|
21103663 |
2011 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the gene coding for emopamil binding protein (EBP) can lead to deficient activity of 3-β-hydroxysteroid Δ(8), Δ(7) isomerase and are most commonly identified in. association with the X-linked dominant (male lethal) chondrodysplasia punctata (CDPX2), also known as Conradi-Hunermann syndrome.
|
20949533 |
2010 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
Biomarker
|
disease |
BEFREE |
Three were microdeletions eliminating PORCN and encompassing neighboring genes such as EBP, the gene associated with Conradi-Hünermann-Happle syndrome (CDPX2).
|
19309688 |
2009 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
Biomarker
|
disease |
CTD_human |
Diagnosis of Conradi-Hünermann-Happle syndrome was confirmed by plasma sterol analysis showing markedly elevated levels of 8(9)-cholestenol and 8-dehydrocholesterol and by detection of a missense mutation (c.307G>A; p.E103K) in the emopamil-binding protein gene.
|
18176751 |
2008 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Diagnosis of Conradi-Hünermann-Happle syndrome was confirmed by plasma sterol analysis showing markedly elevated levels of 8(9)-cholestenol and 8-dehydrocholesterol and by detection of a missense mutation (c.307G>A; p.E103K) in the emopamil-binding protein gene.
|
18176751 |
2008 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Two novel EBP mutations in Conradi-Hünermann-Happle syndrome.
|
18573709 |
2008 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Diagnosis of Conradi-Hünermann-Happle syndrome was confirmed by plasma sterol analysis showing markedly elevated levels of 8(9)-cholestenol and 8-dehydrocholesterol and by detection of a missense mutation (c.307G>A; p.E103K) in the emopamil-binding protein gene.
|
18176751 |
2008 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Prenatal testing for a novel EBP missense mutation causing X-linked dominant chondrodysplasia punctata.
|
18395876 |
2008 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Molecular genetic analysis of the EBP gene revealed a nonsense mutation (c.328C>T, p.R110X), which was previously detected in one CDPX2 patient and in a second female patient, who was only affected on one body side and erroneously diagnosed as CHILD syndrome.
|
17625999 |
2007 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Novel EBP gene mutations in Conradi-Hünermann-Happle syndrome.
|
17949453 |
2007 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
Biomarker
|
disease |
BEFREE |
This study demonstrates that EBP is the gene responsible for CDPX2 across different populations and extends the total number of confirmed mutations to 55.
|
15953085 |
2005 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
Biomarker
|
disease |
BEFREE |
Prior to the recent characterization of the enzymatic defect and identification of the involved gene, the histopathology of X-linked dominant chondrodysplasia punctata (Conradi-Hünermann-Happle syndrome or CDPX2) has been described under various names including calcinosis universalis, chondrodystrophia calcificans congenita, Conradi disease, and Conradi-Hünermann syndrome.
|
14726822 |
2004 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Molecular, biochemical, and phenotypic analysis of a hemizygous male with a severe atypical phenotype for X-linked dominant Conradi-Hunermann-Happle syndrome and a mutation in EBP.
|
12503101 |
2003 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Plasma sterol analysis was a highly specific and sensitive indicator of the presence of an EBP mutation in females with suspected CDPX2, including a clinically unaffected mother of a sporadic case.
|
12509714 |
2003 |
Chondrodysplasia punctata, X-linked dominant type
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
CDPX2 results from mutation of an X-linked gene coding for sterol-delta(8)-delta(7) isomerase (emopamil binding protein).
|
12503102 |
2003 |